Healthcare entity
medical-devices is the sole category represented across all 1 tracked stories. p-tau181/p-tau217 blood tests is most often covered alongside BriDGe study, which appears in 1 of these 1 story. The tracked stories average 3 original sources each. p-tau181/p-tau217 blood tests appears in 1 tracked Healthcare story from July 20, 2026.
Last mentioned: Jul 20, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
medical-devices is the sole category represented across all 1 tracked stories. p-tau181/p-tau217 blood tests is most often covered alongside BriDGe study, which appears in 1 of these 1 story. The tracked stories average 3 original sources each. p-tau181/p-tau217 blood tests appears in 1 tracked Healthcare story from July 20, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 19 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering p-tau181/p-tau217 blood tests. Shared-story counts are live from our verified record — not editorial picks.
A Scottish trial across 50+ GP practices will evaluate p-tau217 blood tests for Alzheimer's in 500 patients, aiming to bring earlier diagnosis into primary care. Success could reduce specialist wait times and transform dementia pathways in the NHS and beyond.
p-tau181/p-tau217 blood tests is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
